Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7039]

ASCO 2019: Colorectal cancer patients with liver metastases live just as long after laparoscopic surgery as open surgery

ASCO 2019: Colorectal cancer patients with liver metastases live just as long after laparoscopic surgery as open...

ASCO 2019: New blood test predicts breast cancer’s return at start of treatment

ASCO 2019: New blood test predicts breast cancer’s return at start of treatment

ASCO 2019: Earlier ovarian cancer diagnoses and treatment seen after ACA implementation

ASCO 2019: Earlier ovarian cancer diagnoses and treatment seen after ACA implementation

Interaction with stromal cells influences tumour growth and metastasis in pancreatic cancer

Interaction with stromal cells influences tumour growth and metastasis in pancreatic cancer

ASCO 2019: 40-50 percent response rate for brigatinib after other next-gen ALK inhibitors

ASCO 2019: 40-50 percent response rate for brigatinib after other next-gen ALK inhibitors

ASCO 2019: Patient groups untested in cancer immunotherapy trials found to also benefit

ASCO 2019: Patient groups untested in cancer immunotherapy trials found to also benefit

New NCCN guidelines for children with cancer meet growing needs of paediatric oncology community worldwide

New NCCN guidelines for children with cancer meet growing needs of paediatric oncology community worldwide

Lifting the lid on bladder cancer support

Lifting the lid on bladder cancer support

ASCO 2019: Delays lead to late-stage diagnosis of young people with colorectal cancer

ASCO 2019: Delays lead to late-stage diagnosis of young people with colorectal cancer

Study reports ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients

Study reports ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic...

More from ecancer